Wednesday, July 8, 2026

biotech · Glaucoma · Hepatocellular Carcinoma · AEON

AEON Biopharma

AEON Biopharma clinical programs — 4 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

irvine, USA HQ
11 Employees
Public company Type
AEON · NYSE Ticker
Company details
Status
Public
HQ
irvine, USA
Employees
11
Programs
9
Drugs
8
Patents
9
Intelligence · Clinical Programs

AEON Biopharma projects

4 ClinicalTrials.gov programs sponsored by AEON Biopharma.

AEON Biopharma has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ABP-450

    AEON Biopharma

    Cervical Dystonia

    phase 2 small molecule completed

    2 trials
  2. ABP-450

    AEON Biopharma

    Migraine

    phase 2 small molecule terminated

    2 trials
  3. Mitomycin C

    AEON Biopharma

    Glaucoma

    phase 2 small molecule completed

    1 trial
  4. Provisc

    AEON Biopharma

    Steroid Induced Glaucoma

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does AEON Biopharma have?

4 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.